Abstract
259TiP Treatment of oligometastatic breast cancer (OMBC): A randomised phase III trial comparing stereotactic ablative radiotherapy (SABR) and systemic treatment with systemic treatment alone as first-line treatment - TAORMINA
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have